{"id":21,"date":"2021-06-27T20:59:00","date_gmt":"2021-06-27T18:59:00","guid":{"rendered":"https:\/\/scholar.semmelweis.hu\/kissrichard\/?page_id=21"},"modified":"2026-04-06T17:35:09","modified_gmt":"2026-04-06T15:35:09","slug":"publikaciok","status":"publish","type":"page","link":"https:\/\/scholar.semmelweis.hu\/kissrichard\/publikaciok\/","title":{"rendered":"Publications"},"content":{"rendered":"
\n

The role of molecular pathology in the diagnosis, prognosis, and management of childhood tumors [HU].<\/b> H\u00f3fer et al.; Orvosi Hetilap, 2025, IF: 0.9, JCI: Q3, co-author<\/p>\n<\/div>\n

\n

Comment on: A Comparative Analysis of Clinical Utility of Cell-Free DNA and Bone Marrow-Based Minimal Residual Disease Assessment in B-Cell Precursor ALL.<\/b> Alp\u00e1r D, Bedics G, Kiss R, Egyed B; Pediatric Blood & Cancer, 2025, IF: 2.9, JCI: Q2, co-author [Letter]\n<\/div>\n

\n

The significance of NTRK inhibition in pediatric neurological diseases [HU].<\/b> Br\u00fcckner E, Kiss R et al.; Gyermekorvos Tov\u00e1bbk\u00e9pz\u00e9s, 2025, co-author<\/p>\n<\/div>\n

\n

Pediatric thyroid-like follicular renal cell carcinoma \u2014 a post-neuroblastoma case with comprehensive genomic profiling data.<\/b> Kiss et al.; Virchows Archive, 2024, IF: 3.1, JCI: Q1, first author<\/p>\n<\/div>\n

\n

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed\/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax.<\/b> Kotmayer et al.; International Journal of Molecular Sciences, 2023, IF: 4.9, JCI: Q1, co-author<\/p>\n<\/div>\n

\n

Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax.<\/b> G\u00e1ng\u00f3 et al.; Pathology, 2022, IF: 2.968, JCI: Q2, co-author<\/p>\n<\/div>\n

\n

Significance of molecular genetic testing in chronic myeloid leukemia [HU].<\/b> Kiss et al.; Orvosk\u00e9pz\u00e9s, 2021, corresponding author<\/p>\n<\/div>\n

\n

The significance of intestinal microbiome in the development, screening and treatment of cancer [HU].<\/b> T\u00f3th et al.; Orvosk\u00e9pz\u00e9s, 2021, corresponding author<\/p>\n<\/div>\n

\n

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed\/refractory chronic lymphocytic leukaemia during ibrutinib therapy.<\/b> B\u00f6d\u00f6r et al.; British Journal of Haematology, 2021, IF: 3.9, JCI: Q1, co-author<\/p>\n<\/div>\n

\n

BCR activated CLL B cells use both CR3 and CR4 for adhesion to complement opsonized targets.<\/b> Nagy-Bal\u00f3 Z, Kiss R et al.; PLOS ONE, 2021, IF: 2.9, JCI: Q2, co-author<\/p>\n<\/div>\n

\n

Retrospective analysis of CML patients treated at Hungarian centers between 2003\u20132019 [HU].<\/b> Weisinger J, T\u00e1rk\u00e1nyi I, Kiss R et al.; Orvosi Hetilap, 2021, IF: 0.9, JCI: Q3, co-author<\/p>\n<\/div>\n

\n

Activated Human Memory B Lymphocytes Use CR4 (CD11c\/CD18) for Adhesion, Migration, and Proliferation.<\/b> Nagy-Bal\u00f3 et al.; Frontiers in Immunology, 2020, IF: 5.9, JCI: Q1, co-author<\/p>\n<\/div>\n

\n

Comprehensive profiling of disease-relevant copy number aberrations for advanced clinical diagnostics of pediatric acute lymphoblastic leukemia.<\/b> Kiss et al.; Modern Pathology, 2020, IF: 5.5, JCI: Q1, first author<\/p>\n<\/div>\n

\n

Dissection of Subclonal Evolution by Temporal Mutation Profiling in Chronic Lymphocytic Leukemia Patients Treated with Ibrutinib.<\/b> G\u00e1ng\u00f3 et al.; International Journal of Cancer, 2020, IF: 4.68, JCI: Q1, co-author<\/p>\n<\/div>\n

\n

Ibrutinib resistance in chronic lymphocytic leukemia [HU].<\/b> Acz\u00e9l et al.; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2019, co-author<\/p>\n<\/div>\n

\n

Cheekbone tumor \u2014 Richter syndrome [HU].<\/b> Csomor, Gy\u00f6rke, Kiss, M\u00e1trai; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2019, co-author<\/p>\n<\/div>\n

\n

Spatial Clonal Evolution Leading to Ibrutinib Resistance and Disease Progression In Chronic Lymphocytic Leukemia.<\/b> Kiss et al.; Haematologica, 2019, IF: 7.9, JCI: Q1, first author<\/p>\n<\/div>\n

\n

Dissection of Subclonal Evolution by Temporal Mutation Profiling in CLL Patients Treated with Ibrutinib [abstract].<\/b> G\u00e1ng\u00f3 A, Alp\u00e1r D, Kiss R et al.; Clinical Lymphoma Myeloma & Leukemia, 2019, co-author<\/p>\n<\/div>\n

\n

Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification [HU].<\/b> Kotmayer et al.; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2018, co-author<\/p>\n<\/div>\n

\n

IGHV mutation analysis in chronic lymphocytic leukemia [HU].<\/b> F\u00e9s\u00fcs et al.; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2018, co-author<\/p>\n<\/div>\n

\n

Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification [HU].<\/b> Kiss et al.; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2018, corresponding author<\/p>\n<\/div>\n

\n

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms.<\/b> G\u00e1ng\u00f3 et al.; Leukemia Research, 2018, IF: 1.62, JCI: Q2, co-author<\/p>\n<\/div>\n

\n

Multiplex ligation-dependent probe amplification in oncohematological diagnostics and research [HU].<\/b> Kiss et al.; Orvosi Hetilap, 2018, IF: 0.9, JCI: Q3, first author<\/p>\n<\/div>\n

\n

High-Throughput Copy Number Profiling by Digital Multiplex Ligation-Dependent Probe Amplification in Multiple Myeloma.<\/b>Kosztol\u00e1nyi and Kiss et al.; Journal of Molecular Diagnostics, 2018, IF: 3.4, JCI: Q1, first author<\/p>\n<\/div>\n

\n

Familial Acute Myeloid Leukemia and Myelodysplasia in Hungary.<\/b> Kir\u00e1ly et al.; Pathology & Oncology Research, 2018, IF: 2.14, JCI: Q2, co-author<\/p>\n<\/div>\n

\n

Dissection of Clonal Evolution By Temporal Mutation Profiling in Chronic Lymphocytic Leukemia [abstract].<\/b> Alp\u00e1r D, Marosv\u00e1ri D, Kiss R et al.; Blood (ASH Annual Meeting Abstracts), 2017, co-author<\/p>\n<\/div>\n

\n

Functional studies of chronic lymphocytic leukemia B cells expressing \u03b22-integrin type complement receptors CR3 and CR4.<\/b>Uzonyi et al.; Immunology Letters, 2017, IF: 2.61, JCI: Q2, co-author<\/p>\n<\/div>\n

\n

Novelties and experiences in the tyrosine kinase inhibitor treatment of chronic myeloid leukemia.<\/b> Ga\u00e1l-Weisinger et al.; Magyar Onkol\u00f3gia, 2017, IF: 0.51, JCI: Q4, co-author<\/p>\n<\/div>\n

\n

Current issues in molecular monitoring of chronic myeloid leukemia [HU].<\/b> Kiss et al.; Magyar Onkol\u00f3gia, 2017, IF: 0.51, JCI: Q4, first author<\/p>\n<\/div>\n

\n

Significance of deep molecular response in chronic myeloid leukemia \u2014 Report on Hungarian standardization program in BCR-ABL1 monitoring [HU].<\/b> Andrikovics et al.; Hematol\u00f3gia\u2013Transzfuziol\u00f3gia, 2017, co-author<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The role of molecular pathology in the diagnosis, prognosis, and management of childhood tumors [HU]. H\u00f3fer et al.; Orvosi Hetilap, 2025, IF: 0.9, JCI: Q3, co-author Comment on: A Comparative Analysis of Clinical Utility of …<\/p>\n","protected":false},"author":125,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-21","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/pages\/21"}],"collection":[{"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/comments?post=21"}],"version-history":[{"count":7,"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/pages\/21\/revisions"}],"predecessor-version":[{"id":70,"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/pages\/21\/revisions\/70"}],"wp:attachment":[{"href":"https:\/\/scholar.semmelweis.hu\/kissrichard\/wp-json\/wp\/v2\/media?parent=21"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}